Covid-19
Estudo de coorte | Efeitos dos lockdowns ocorridos na pandemia de COVID-19 sobre as cirurgias oncológicas eletivas para 15 tipos de tumores em 61 países.
8 Out, 2021 | 11:25h
Comentário no Twitter (fio – clique para saber mais)
What were the unintended consequences of COVID lockdowns on cancer care?@CovidSurg study in @TheLancetOncol:
🔹Lockdowns independently associated with delayed treatment
🔹At median 5.3 months f/u, 1 in 7 pts had not had planned cancer surgery🆓https://t.co/UZe0euq5kg pic.twitter.com/4fPl6UEb9D
— Dmitri Nepogodiev (@dnepo) October 5, 2021
O que se sabe – e o que não se sabe – sobre a nova pílula da Merck para Covid-19.
8 Out, 2021 | 11:23hWhat we know — and don’t know — about Merck’s new Covid-19 pill – STAT
Conteúdos relacionados:
Merck’s Covid-19 pill is great news but may not be a game-changer.
Video | A Pill For COVID? A Doctor Explains Molnupiravir.
Opinião | Por que os americanos ainda – Ainda! – estão usando máscaras de tecido?
8 Out, 2021 | 11:21hWhy Are Americans Still—Still!—Wearing Cloth Masks? – The Atlantic
Conteúdos relacionados:
Evidence shows that, yes, masks prevent COVID-19 – and surgical masks are the way to go.
[Preprint] Largest study of masks yet details their importance in fighting Covid-19.
Comentário no Twitter
Any mask is better than no mask, especially indoors. But for those who are at higher risk of severe disease or around lots of unvaccinated people, consider upgrading to an N95 (or equivalent) mask, which are more protective. https://t.co/vhNPadTP8O
— Dr. Tom Frieden (@DrTomFrieden) October 5, 2021
Estudo de coorte | Efetividade da vacina da Pfizer contra qualquer infecção caiu de 88% no 1º mês após a vacinação completa para 47% após 5 meses. A efetividade da vacina contra internações permaneceu alta: 87% em 1 mês e 88% depois de 5 meses da vacinação completa, sem declínio significativo.
5 Out, 2021 | 11:36hComentário: Expert reaction to study on Pfizer-BioNTech vaccine effectiveness up to 6 months – Science Media Centre
Comentário no Twitter
Study of 3.4 million people @aboutKP @TheLancet
Vaccine efficacy against infections:
– First month post: 88%
– 5 months post: 47%But vaccine efficacy against hospitalization (Figure):
– First month post: 87%
– 5 months post: 88 %https://t.co/1Gse0FKpoI pic.twitter.com/p9wyiaWGeg— Vincent Rajkumar (@VincentRK) October 4, 2021
Estudo de coorte | Miocardite aguda após vacina de mRNA contra COVID-19 em maiores de 18 anos é rara, e a maioria dos casos não é grave.
5 Out, 2021 | 11:34hEditorial: COVID-19 Messenger RNA Vaccination and Myocarditis—A Rare and Mostly Mild Adverse Effect
Comentário no Twitter
New report on very rare acute myocarditis after mRNA vaccination in age 18+
5.8 cases/million after 2nd dose, 0.8/million 1st dose, all cases fully resolved with conservative managementhttps://t.co/Mfh5ImiSpW @KPSCALnews @KPSCalResearch @JAMAInternalMed— Eric Topol (@EricTopol) October 4, 2021
Estudo randomizado | Mais um estudo mostra que plasma convalescente não melhora os desfechos em pacientes criticamente doentes com Covid-19.
5 Out, 2021 | 11:32hConteúdos relacionados:
M-A: Convalescent plasma is safe but does not improve outcomes in the treatment of COVID-19.
RECOVERY Trial: No benefit from convalescent plasma in patients admitted to hospital with COVID-19.
COVID-19 e doença metabólica: mecanismos e abordagem clínica.
5 Out, 2021 | 11:31hConteúdo relacionado: Review | Interplay between endocrinology, metabolism, and COVID-19 infection.
Nova Zelândia reconhece que não conseguirá mais ficar completamente livre do coronavírus.
5 Out, 2021 | 11:29hNew Zealand acknowledges it can no longer completely get rid of the coronavirus – NPR
Ver também:
New Zealand admits it can no longer get rid of coronavirus – Associated Press
Battling Delta, New Zealand Abandons Its Zero-Covid Ambitions – The New York Times
Pílula da Merck contra Covid-19 é uma ótima notícia, mas pode não ser uma grande mudança.
5 Out, 2021 | 11:28hMerck’s Covid-19 pill is great news but may not be a game-changer – CNN
Vídeo | Uma pílula para COVID? Um médico explica o molnupiravir.
5 Out, 2021 | 11:26hA Pill For COVID? | A Doctor Explains Molnupiravir – ZDoggMD